Louchez MM - Search Results

1

Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients.

Hebbar M, Révillion F, Louchez MM, Fournier C, Bonneterre J, Peyrat JP. Hebbar M, et al. Among authors: louchez mm. Clin Cancer Res. 1999 Jun;5(6):1427-33. Clin Cancer Res. 1999. PMID: 10389928

2

Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer.

Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A. Peyrat JP, et al. Among authors: louchez mm. Eur J Cancer. 1993;29A(4):492-7. doi: 10.1016/s0959-8049(05)80137-6. Eur J Cancer. 1993. PMID: 8435198

3

The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.

Hebbar M, Révillion F, Louchez MM, Vilain MO, Fournier C, Bonneterre J, Peyrat JP. Hebbar M, et al. Among authors: louchez mm. Clin Cancer Res. 1998 Feb;4(2):373-80. Clin Cancer Res. 1998. PMID: 9516925

4

Basic fibroblast growth factor receptors and their prognostic value in human breast cancer.

Blanckaert VD, Hebbar M, Louchez MM, Vilain MO, Schelling ME, Peyrat JP. Blanckaert VD, et al. Among authors: louchez mm. Clin Cancer Res. 1998 Dec;4(12):2939-47. Clin Cancer Res. 1998. PMID: 9865904

5

Distribution and prognostic value of the fibroblast growth factor-2 low-affinity binding sites in human breast cancer.

Blanckaert VD, Hornez L, Hebbar M, Louchez MM, Hondermarck H, Peyrat JP. Blanckaert VD, et al. Among authors: louchez mm. Anticancer Res. 2000 Sep-Oct;20(5C):3913-8. Anticancer Res. 2000. PMID: 11268476

6

mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.

Revillion F, Pawlowski V, Lhotellier V, Louchez MM, Peyrat JP. Revillion F, et al. Among authors: louchez mm. Anticancer Res. 2003 Mar-Apr;23(2B):1455-60. Anticancer Res. 2003. PMID: 12820409

7

Basic fibroblast growth factor (bFGF): mitogenic activity and binding sites in human breast cancer.

Peyrat JP, Bonneterre J, Hondermarck H, Hecquet B, Adenis A, Louchez MM, Lefebvre J, Boilly B, Demaille A. Peyrat JP, et al. Among authors: louchez mm. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):87-94. doi: 10.1016/0960-0760(92)90191-k. J Steroid Biochem Mol Biol. 1992. PMID: 1525070

8

Demonstration of basic fibroblast growth factor high and low affinity binding sites in human breast cancer cell lines.

Peyrat JP, Hondermark H, Louchez MM, Boilly B. Peyrat JP, et al. Among authors: louchez mm. Cancer Commun. 1991;3(10-11):323-9. doi: 10.3727/095535491820873803. Cancer Commun. 1991. PMID: 1662060

9

Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer.

Vennin P, Peyrat JP, Bonneterre J, Louchez MM, Harris AG, Demaille A. Vennin P, et al. Among authors: louchez mm. Anticancer Res. 1989 Jan-Feb;9(1):153-5. Anticancer Res. 1989. PMID: 2539768

10

Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease.

Peyrat JP, Bonneterre J, Laurent JC, Louchez MM, Amrani S, Leroy-Martin B, Vilain MO, Delobelle A, Demaille A. Peyrat JP, et al. Among authors: louchez mm. Eur J Cancer Clin Oncol. 1988 Sep;24(9):1425-31. doi: 10.1016/0277-5379(88)90332-x. Eur J Cancer Clin Oncol. 1988. PMID: 2972546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters